PRESS RELEASE published on 08/13/2025 at 14:45, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT plc The Vanguard Group, Inc. discloses 5.72% interest in Tritax Big Box REIT plc as of 12 August 2025 per Form 8.3 under the Takeover Code The Vanguard Group, Inc. Form 8.3 Takeover Code Tritax Big Box REIT Plc Interest Disclosure
PRESS RELEASE published on 08/13/2025 at 14:44, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses a 4.55% ownership in Unite Group plc. No other party involved in the offer. Details of stock purchase included Vanguard Group Ownership Disclosure Financial Disclosure Unite Group Plc Stock Purchase Disclosure
BRIEF published on 08/12/2025 at 14:43, 1 year 1 month ago The Vanguard Group Discloses Position in Qualcomm Investment Strategy Form 8.3 Vanguard Group Shareholding Qualcomm
BRIEF published on 08/12/2025 at 14:42, 1 year 1 month ago The Vanguard Group's Stake in American Axle & Manufacturing Holdings Form 8.3 Shareholding Securities Transaction American Axle Vanguard Disclosure
BRIEF published on 08/12/2025 at 14:41, 1 year 1 month ago The Vanguard Group Discloses Position in Mural Oncology plc Securities Disclosure Irish Takeover Panel Vanguard Group Mural Oncology
PRESS RELEASE published on 08/12/2025 at 14:38, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.65% interest in Qualcomm Incorporated. Form 8.3 filing as of 11 August 2025 Form 8.3 Vanguard Group Stock Market Interest Disclosure Qualcomm
PRESS RELEASE published on 08/12/2025 at 14:37, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.62% ownership position in American Axle & Manufacturing Holdings, Inc. as of 11 August 2025 The Vanguard Group, Inc. Disclosure Ownership Position American Axle & Manufacturing Holdings, Inc. 11 August 2025
PRESS RELEASE published on 08/12/2025 at 14:36, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% ownership in Mural Oncology plc as of 11 August 2025. No additional party disclosures made Irish Takeover Panel Vanguard Group Ownership Disclosure Financial Disclosure Mural Oncology Plc
BRIEF published on 08/11/2025 at 15:30, 1 year 1 month ago Vanguard Group Discloses Position in Qualcomm Form 8.3 Takeover Code Vanguard Group Stock Positions Qualcomm Securities
BRIEF published on 08/11/2025 at 15:30, 1 year 1 month ago The Vanguard Group Discloses Position in American Axle & Manufacturing Holdings Form 8.3 The Vanguard Group Takeover Code Investment Disclosure American Axle
Published on 09/12/2026 at 02:35, 1 day 1 hour ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 4 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 6 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 10 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 10 hours 1 minute ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 20 hours 21 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 5 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 5 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 8 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 20 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 8 hours ago Availability of the 2026 Interim Financial Report
